Interestingly, the effect of adjuvant IFN-α on postoperative recurrence differs between HBV-HCC and HCV-HCC cases, indicating different strategies with adjuvant IFN-α should be used to treat HCC with different backgrounds. Here, IFNA1 is linked to hepatocellular carcinoma.